Gold rises as weaker dollar, Trumps Powell criticism fuel uncertainty
US dollar falls to lowest level since March 2022
Powell says Fed needs to manage inflation risk
Trump criticizes Federal Reserve chair Powell as "terrible"
June 26 - Gold prices edged higher on Thursday, lifted by a weaker dollar and growing uncertainty after reports suggested U.S. President Donald Trump had considered replacing Federal Reserve Chair Jerome Powell as early as September or October.
The reports raised concerns over the future independence of the U.S. central bank, boosting demand for safe-haven bullion.
Spot gold was up 0.2% at $3,339.20 per ounce, as of 0242 GMT. U.S. gold futures rose 0.3% to $3,353.10.
The dollar fell to its lowest level since March 2022, making greenback-priced gold less expensive for overseas buyers.
Powell told a U.S. Senate panel on Wednesday that while Trump's tariffs may cause a one-time price hike, the risk of persistent inflation is significant enough for the central bank to be cautious about further rate cuts.
"Trump clearly wants a dovish Fed Chairman next time around, so the increased likelihood of an aggressive rate-cutting cycle is pinning down the USD," KCM Trade Chief Market Analyst Tim Waterer said.
Bullion tends to do well during periods of uncertainty and in a low-interest-rate environment.
On Wednesday, Trump called Powell "terrible" and said he is considering three or four candidates for the top Fed post.
Meanwhile, The Wall Street Journal reported that Trump has even toyed with the idea of announcing Powell's potential successor by September or October.
Markets are awaiting U.S. GDP print due later in the day, while also keeping a watch for data on Personal Consumption Expenditures on Friday.
"Gold is just basically treading water for the moment until we get a read on the next batch of U.S. macro data including GDP and core PCE," Waterer said.
A ceasefire between Israel and Iran appeared to be holding on Wednesday as Trump, at a NATO summit, praised the swift end to the 12-day conflict and said he would seek a commitment from Iran to end its nuclear ambitions at talks next week.
Spot silver edged up 0.2% to $36.36 per ounce, platinum firmed 2.3% to $1,385.38, while palladium surged 5.5% to $1,115.58.
This article was generated from an automated news agency feed without modifications to text.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
14 minutes ago
- New Indian Express
Indian banks still prefer funding fossil fuels project amid rising risk to investment: Report
NEW DELHI: Even as India aggressively pushes for a clean energy transition, Indian banks have substantially financed fossil fuel and coal-fired power projects—totalling approximately USD 29 billion between 2016 and 2023—which could hinder and complicate the path to achieving net-zero emissions, states a recent report. Prepared by Climate Risk Horizon, a Bangalore-based non-profit organisation that monitors climate-related risks for investors, the report highlights that the State Bank of India (SBI) and private lenders such as Axis Bank and ICICI Bank were among the top financiers of coal. Titled 'Stuck in the Past: Coal Ties Hinder Indian Banks' Energy Transition' the report indicates that India's leading banks invested around USD 29 billion in coal during the specified period. Of this amount, approximately USD 15.2 billion was provided as coal loans, while USD 13.5 billion was allocated to coal underwriting services Further segregating the data, the analysis shows that public banks provided roughly 75% of the coal loans while private banks financed roughly 83% of the total underwriting. According to the report, over these eight years, the amount of coal loans fluctuated significantly. Still, coal underwriting by Indian banks remained relatively stable with an average of USD 1.7 billion per year. Underwriting service is a process of mitigating risk for financial transactions by financial institutions by guaranteeing repayment in case of damage or financial loss.
Business Standard
26 minutes ago
- Business Standard
Nifty trades tad above 25,400 level; oil & gas shares in demand
The frontline indices traded with major gains in the afternoon trade, supported by optimism over the Iran-Israel ceasefire. Positive global cues from Asian markets and institutional activity influenced market sentiment. The Nifty traded tad above the 25,400 level. Oil & gas, metal and private bank shares advanced, while realty, media and IT shares declined. At 13:30 IST, the barometer index, the S&P BSE Sensex, jumped 547.04 points or 0.66% to 83,302.55. The Nifty 50 index added 153.20 points or 0.61% to 25,404.80. In the broader market, the S&P BSE Mid-Cap index rose 0.12% and the S&P BSE Small-Cap index shed 0.07%. The market breadth was negative. On the BSE, 1,969 shares rose and 1,908 shares fell. A total of 170 shares were unchanged. Gainers & Losers: Adani Ports and Special Economic Zone (up 2.48%), Jio Financial Services (up 2.46%), Bajaj Finance (up 2.21%), HDFC Life Insurance Company (up 1.75%) and Shriram Finance (up 1.61%) were the major Nifty50 gainers. Dr. Reddy's Laboratories (down 1.80%), Tech Mahindra (down 1.65%), Trent (down 1.27%), Hero MotoCorp (down 0.99%) and Mahindra & Mahindra (down 0.78%) were the major Nifty50 Losers. Stocks in Spotlight: OM Infra soared 7.07% after the company secured a turnkey contract from NHPC for hydro-mechanical works at India's largest power generation project, the 2880 MW Dibang Project in Arunachal Pradesh. Ask Automotive added 3.36% after its board approved entering into a joint venture with T.D. Holding GMBH (TDH) to manufacture, market, and sell sunroof control cables and helix cables for passenger vehicles through a joint venture company. KNR Constructions shed 0.35% after the company announced that its joint venture KNRCL-HCPL has received a letter of acceptance worth Rs 4,800.57 crore for a major coal mining project in Jharkhand. Global Markets: European stocks edged higher, while Asian shares traded mixed on Thursday, as investors weighed the Israel-Iran ceasefire, an upcoming U.S. tariff deadline, and fresh remarks from Fed Chair Jerome Powell. Late Monday, President Trump announced a multi-stage truce between the two nations, urging both sides to hold the line. By Wednesday, the ceasefire seemed to be sticking, just a day after both countries said they had wrapped up a 12-day aerial showdown. U.S. Secretary of State Marco Rubio claimed Iran is now "much further" from building a nuclear weapon post-strikes, downplaying intelligence that says the air raids merely bought a few extra months. Trump, meanwhile, credited the swift U.S. military response for ending the skirmish and said he plans to push Iran to abandon its nuclear ambitions during talks next week. Back in the U.S., shares ended Wednesday on a subdued note. The S&P 500 hovered near the flatline, closing at 6,092.16 as investors looked for clues on whether it could challenge its all-time high. The Nasdaq inched up 0.31%, while the Dow slipped 0.25%. Federal Reserve Chair Jerome Powell wrapped up his Capitol Hill testimony, continuing to strike a cautious tone on inflation and trade. While he left the door open for future rate cuts if recent pressures prove short-lived, he avoided committing to any timeline, despite mounting pressure from President Trump. NVIDIA hit a fresh all-time high after Loop Capital boosted its price target to $250 from $175, pointing to strong and sustained demand for AI chips as artificial intelligence adoption surges. FedEx shares dropped over 3% after the company issued a weaker-than-expected profit forecast for the current quarter.
Business Standard
27 minutes ago
- Business Standard
Lupin launches Prucalopride Tablets in US market
Lupinannounced the launch of Prucalopride Tablets, 1 mg, and 2 mg, in the United States, following the recent approval of its Abbreviated New Drug Application (ANDA) from the U.S. FDA. Prucalopride Tablets are bioequivalent to Motegrity Tablets, 1 mg and 2 mg, of Takeda Pharmaceuticals U.S.A. Inc., and indicated for the treatment of chronic idiopathic constipation (CIC) in adults. Prucalopride Tablets, 1 mg, and 2 mg (RLD Motegrity) had estimated annual sales of USD 184 million in the U.S. (IQVIA MAT April 2025).
